BIOS Fund III, LP
Follow-ons only
Follow-ons only: first sale Dec 2019, per Form D (fund age approximates vintage)
- Vintage
- 2019
- Fund size
- $3.29M to $100M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- US
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$33K to $1.67M (estimated from fund size)
Estimated from Form D: $3.29M sold of a $100M target
03 · Who to approach
Named on this fund's Form D
- Aaron Fletcher, Managing Partner of BIOS Equity Partners III, LP and Manager of BIOS Advisors GP, LLC.
- Leslie Kreis, Jr., Managing Partner of BIOS Equity Partners III, LP and Manager of each of CAVU Advisors, LLC and Steelhead Capital Management, LLC.
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideBios Partners is a venture capital firm focused on advanced biotech in overlooked and under-invested markets in the U.S., and invests in opportunities with compelling science across the Central US.
Bios Partners is a venture capital firm identifying advanced biotech in overlooked and under-invested markets in the U.S.
https://biospartners.com/
06 · Sources
Last verified: Oct 25, 2026